Late Phase II Study of TS-142 in Patients With Insomnia

  • STATUS
    Recruiting
  • participants needed
    160
  • sponsor
    Taisho Pharmaceutical Co., Ltd.
Send
Updated on 19 May 2022
See if I qualify

Summary

This is a randomized, double-blind, multi-center, placebo-controlled, parallel-group exploratory study in patients with insomnia.

Details
Condition Patients With Insomnia
Treatment TS-142
Clinical Study IdentifierNCT04469023
SponsorTaisho Pharmaceutical Co., Ltd.
Last Modified on19 May 2022

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note